Skinner As Self-Manager.

Por Epstein, R
Publicado em 1997

Amount consumed varies as a function of feeder design.

Por Epstein, R
Publicado em 1985

"Leaving town" versus "taking leave": the case for re-thinking academic leave restrictions

Por Epstein, R
Publicado em 2005

Treating breast cancer before surgery.

Por Epstein, R.
Publicado em 1996

Six authors in search of a citation: villains or victims of the Vancouver convention?

Por Epstein, R J
Publicado em 1993

Drug wars in the United States.

Por Epstein, R. J.
Publicado em 1989

THEORY OF GAMBLING AND STATISTICAL LOGIC.

Por EPSTEIN R A.
Publicado em S1967

Endocrine treatment of cancer.

Por Gulliford, T, Epstein, R J
Publicado em 1996

Heterosynaptic facilitation and post-tetanic potentiation in Aplysia nervous system

Por Epstein, R., Tauc, L.
Publicado em 1970

Resurgence of responding after the cessation of response-independent reinforcement.

Por Epstein, R, Skinner, B F
Publicado em 1980

Method for Rupturing Large Quantities of Microorganisms

Por Garver, J. C., Epstein, R. L.
Publicado em 1959

Teenagers' health concerns: implications for primary health care professionals.

Por Epstein, R, Rice, P, Wallace, P
Publicado em 1989

A new indirect ophthalmoscope prototype.

Por Devonshire, R, Peyman, G A, Epstein, R
Publicado em 1981

Time of gene expression in relation to centromere distance during the cell cycle of Saccharomyces cereviseae.

Por Tauro, P, Halvorson, H O, Epstein, R L
Publicado em 1968

A Comparative Genetic Study of Conditional Lethal Mutations of Bacteriophage T4d

Por Edgar, R. S., Denhardt, G. H., Epstein, R. H.
Publicado em 1964

Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction.

Por Huang, G C, Ouyang, X, Epstein, R J
Publicado em 1998

Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study.

Por Gulliford, T., Opomu, M., Wilson, E., Hanham, I., Epstein, R.
Publicado em 1997

Dominant negative knockout of p53 abolishes ErbB2-dependent apoptosis and permits growth acceleration in human breast cancer cells

Por Huang, G C, Hobbs, S, Walton, M, Epstein, R J
Publicado em 2002

Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer

Por Wong, H, Lau, S, Yau, T, Cheung, P, Epstein, R J
Publicado em 2010

Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAF(V600E)-mutant metastatic colorectal carcinoma

Por Connolly, K., Brungs, D., Szeto, E., Epstein, R.J.
Publicado em 2014